Anika Therapeutics, Inc. (ANIK) CEO Cheryl Blanchard on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha]
Anika Therapeutics Inc. (ANIK)
Last anika therapeutics inc. earnings: 2/20 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.anikatherapeutics.com/investor-relations
Company Research
Source: Seeking Alpha
Anika Therapeutics, Inc. (NASDAQ: ANIK Company Participants Sylvia Cheung - CFO, Treasurer & Secretary Cheryl Blanchard - Interim CEO & Director James Loerop - EVP, Business Development & Strategic Planning Conference Call Participants Joseph Munda - First Analysis Michael Petusky - Barrington Research Associates James Sidoti - Sidoti & Company Operator Good evening, ladies and gentlemen, and welcome to Anika Therapeutics Fourth Quarter and Full Year 2019 Earnings Conference Call. [Operator Instructions]. I will now turn the call over to Sylvia Cheung, Chief Financial Officer. Please proceed. Thank you, Lide. Good evening, everyone, and thank you for joining us. With me on the call today is Dr. Cheryl Blanchard, Interim Chief Executive Officer; and Jim Loerop, Executive Vice President of Business Development and Strategic Planning. During today's call, Cheryl, Jim and I will review our fourth quarter and full year 2019 financial results and key business highlights, which were summariz
Show less
Read more
Impact Snapshot
Event Time:
ANIK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIK alerts
High impacting Anika Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
ANIK
News
- Anika Therapeutics, Inc. (NASDAQ: ANIK) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $37.00 to $25.00. They now have an "outperform" rating on the stock.MarketBeat
- Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]Yahoo! Finance
- Arthrosurface Returns to it Roots Following Divestiture from Anika TherapeuticsPR Newswire
- Anika Reports Third Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
ANIK
Earnings
- 10/31/24 - Miss
ANIK
Sec Filings
- 11/4/24 - Form 10-Q
- 10/31/24 - Form 8-K
- 10/31/24 - Form 8-K
- ANIK's page on the SEC website